Mammary Reconstruction Clinical Trial
Official title:
Use of the Venous Coupler in Breast Reconstruction by Means of a Deep Inferior Epigastric Perforator: Reduction of Surgery Length and Venous Thromboses ?
Verified date | May 2018 |
Source | Brugmann University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This is a retrospective study performed on medical records, in order to compare the number of venous thromboses, the surgery duration, the complications rate and the duration of anastomosis in breast reconstructive surgeries by the DIEP (Deep Inferior Epigastric Perforator Flap) technique, with or without the use of a venous coupler.
Status | Completed |
Enrollment | 40 |
Est. completion date | May 28, 2018 |
Est. primary completion date | May 28, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 25 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Total mastectomy with mammary reconstruction by the DIEP technique - Patients treated within the CHU Brugmann Hospital - Patients treated between 01/01/2017 and 01/09/2017 Exclusion Criteria: |
Country | Name | City | State |
---|---|---|---|
Belgium | CHU Brugmann | Brussels |
Lead Sponsor | Collaborator |
---|---|
Brugmann University Hospital |
Belgium,
Camara O, Herrmann J, Egbe A, Koch I, Gajda M, Runnebaum IB. Venous coupler for free-flap anastomosis. Anticancer Res. 2009 Jul;29(7):2827-30. — View Citation
Kulkarni AR, Mehrara BJ, Pusic AL, Cordeiro PG, Matros E, McCarthy CM, Disa JJ. Venous Thrombosis in Handsewn versus Coupled Venous Anastomoses in 857 Consecutive Breast Free Flaps. J Reconstr Microsurg. 2016 Mar;32(3):178-82. doi: 10.1055/s-0035-1563737. Epub 2015 Sep 15. — View Citation
Rozen WM, Whitaker IS, Acosta R. Venous coupler for free-flap anastomosis: outcomes of 1,000 cases. Anticancer Res. 2010 Apr;30(4):1293-4. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of venous thrombosis | Rate of venous thrombosis | Up to 1 week after mammary reconstruction surgery | |
Primary | Surgery duration | Duration of the mammary reconstruction surgery with the DIEP technique | At the date of mammary reconstruction surgery. | |
Primary | Anastomosis duration | Duration of the anastomosis during the mammary reconstruction surgery | At the date of mammary reconstruction surgery. | |
Secondary | Age | Patient age | At the date of mammary reconstruction surgery. | |
Secondary | Body mass index | Body mass index | At the date of mammary reconstruction surgery. | |
Secondary | Tabagism | Tabagism status (smoker/non smoker) | At the date of mammary reconstruction surgery. | |
Secondary | Co-morbidity : diabetes | Medical history of diabetes | At the date of mammary reconstruction surgery. | |
Secondary | Co-morbidity : cardio-vascular disease | Medical history of cardio-vascular disease | At the date of mammary reconstruction surgery. | |
Secondary | Co-morbidity : medical history of venous thrombosis | Medical history of venous thrombosis | At the date of mammary reconstruction surgery. | |
Secondary | Immediate of differed reconstruction | Reconstruction performed immediately after mastectomy or not | At the date of mammary reconstruction surgery. | |
Secondary | Unilateral or Bilateral DIEP | Unilateral or Bilateral DIEP | At the date of mammary reconstruction surgery. | |
Secondary | Medical complications (yes/no) | Medical complications within the grafted flap | Up to one week after mammary reconstruction surgery | |
Secondary | Type of cancer treatment | (neo)adjuvant chemiotherapy or (neo)adjuvant radiotherapy | At the date of mammary reconstruction surgery. |